-
Diuron-Induced Acute Kidney Injury: Mechanistic Insights
2026-09-14
The reference study integrates network toxicology, molecular docking, transcriptomic validation, and HK-2 cell experiments to investigate how Diuron may cause acute kidney injury. Its findings identify JAK2/STAT1 signaling as a candidate mechanism of renal toxicity and provide a framework for connecting computational toxicology with experimentally measurable cellular responses.
-
Acifran Workflows for HCAR Lipid Signaling
2026-09-14
Acifran enables receptor-proximal studies of HCAR2/GPR109A and HCAR3/GPR109B signaling before researchers commit to broader lipid-metabolism phenotyping. This workflow combines cAMP assays, matched receptor systems, structural insight, and practical handling controls to improve interpretation in metabolic disorder research.
-
Hoechst 33342: A Smarter Senescence Readout
2026-09-13
Learn how Hoechst 33342 nuclear stain can function as more than a fluorescent label in fibroblast senescence studies. This guide develops an assay architecture that links nuclear normalization, mitochondrial quality measurements, imaging, and flow cytometry while preserving biological interpretation.
-
Safe DNA Gel Stain for Wheat Genotyping
2026-09-12
Safe DNA Gel Stain supports blue-light nucleic acid visualization for wheat genotyping, cloning, and routine DNA and RNA gel analysis. Its direct-in-gel and post-electrophoresis formats help reduce reliance on UV imaging while preserving a practical path from PCR screening to plant-breeding decisions.
-
GSH-Responsive MOF Nanoparticles for Melanoma Therapy
2026-09-11
Hao and colleagues developed ICG-MOF-SS-AUNP12, a zirconium-based metal–organic framework nanoparticle that combines near-infrared photothermal therapy with glutathione-responsive PD-1/PD-L1 blockade. The study shows how stimulus-responsive cargo release and immune activation can be integrated into one melanoma nanomedicine, while also highlighting the experimental controls needed before translating indocyanine-green imaging chemistry into independent workflows.
-
Methyl-β-cyclodextrin: Practical Membrane Guide
2026-09-11
Methyl-β-cyclodextrin (SKU C6939) provides a soluble way to perturb membrane cholesterol and lipid organization in controlled biochemical and cell-based workflows. It is intended for research use only, not diagnostic or medical applications, and working solutions should be prepared promptly rather than stored long term.
-
Trypsin-Responsive Nanomedicine for Acute Pancreatitis
2026-09-10
This ACS Nano study develops a biomimetic mesoporous organosilica nanoparticle that combines acinar-cell targeting with trypsin-triggered BAPTA-AM release. In a mouse model of acute pancreatitis, the formulation reduced intracellular calcium overload, suppressed inflammatory and necrotic signaling, improved pancreatic biomarkers, and increased survival, while also illustrating the translational challenges of complex membrane-coated nanomedicines.
-
TMRE: Mapping Mitochondrial Injury to Mechanism
2026-09-10
A translational framework for using Tetramethylrhodamine ethyl ester perchlorate (TMRE, SKU: C8197) to connect mitochondrial membrane potential with ROS, apoptosis, and toxin-induced liver injury. The article interprets a recent non-peer-reviewed preprint mechanistically while outlining assay design, controls, limitations, and opportunities for more decision-ready mitochondrial research.
-
HPF for Mechanistic ROS Mapping in Copper Therapy
2026-09-09
HPF (hydroxyphenyl fluorescein) provides a selective green-fluorescence readout of highly reactive oxygen species. This guide explains how to use it as a mechanistic assay in copper-based nanotherapy, distinguishing hROS formation from photodynamic activity and cuproptosis.
-
Diuron Workflows for Plant and Toxicology Research
2026-09-09
Diuron can support two complementary research tracks: controlled photosynthesis-inhibition studies and mechanistic toxicology workflows focused on renal injury. This guide translates product specifications and recent JAK2/STAT1 findings into practical preparation, dosing, assay-selection, and troubleshooting decisions.
-
Epirubicin, B56δ, and Kidney Fibrosis
2026-09-08
A 2026 Kidney Diseases study identifies epirubicin as a small-molecule inhibitor of the PP2A regulatory subunit B56δ and links this intervention to reduced renal lipid accumulation and fibrosis in mouse and tubular-cell models. The work supports a more selective strategy than direct PP2Acα inhibition, while its preclinical design leaves important questions about mechanism, dosing, and translational safety.
-
PXDN–LDHA Glycolysis in Glioblastoma
2026-09-08
The reference study identifies peroxidasin (PXDN) as a glycolysis-associated driver of glioblastoma progression and places LDHA downstream of this effect. Its combination of transcriptomic network analysis, cellular perturbation, rescue experiments, and in vivo validation provides a useful framework for connecting metabolic biomarkers with malignant phenotypes.
-
IR-820: In Vivo Imaging Workflows and Optimization
2026-09-07
IR-820 (New Indocyanine Green) supports near-infrared fluorescence imaging of blood vessels, tumors, and other diseased tissues with quantitative workflow potential. This guide connects practical assay setup with the reference study’s nanoplatform strategy while separating validated findings from optimization recommendations.
-
DiI (DiIC18(3)) Plasma Membrane Probe
2026-09-07
DiI (DiIC18(3)) provides orange-red labeling of lipid bilayers for membrane visualization, neuronal tracing, migration studies, and related live or fixed-tissue workflows. It should be prepared in an organic solvent rather than water, and membrane localization must be rechecked after fixation or permeabilization.
-
Methyl-β-cyclodextrin Membrane Workflow Guide
2026-09-05
Methyl-β-cyclodextrin supports controlled membrane cholesterol extraction for experiments examining membrane organization, fluidity, and cholesterol-sensitive signaling. It is a research reagent only; concentration, exposure time, solvent, and cell-model compatibility must be established experimentally rather than treated as universal conditions.